BioCentury
ARTICLE | Clinical News

RHB-104 regulatory update

January 25, 2017 2:43 AM UTC

FDA granted Qualified Infectious Disease Product (QIDP) and Fast Track designation to RHB-104 from RedHill to treat non-tuberculosis mycobacterial (NTM) infections. The product is a capsule formulatio...

BCIQ Company Profiles

RedHill Biopharma Ltd.